The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
Abstract
Purpose: To provide an updated joint ASCO/Infectious Diseases Society of America (IDSA) guideline on antimicrobial prophylaxis for adult patients with immunosuppression associated with cancer and its treatment. Methods: ASCO and IDSA convened an update Expert Panel and conducted a systematic review of relevant studies from May 2011 to November 2016. The guideline recommendations were based on the review of evidence by the Expert Panel. Results: Six new or updated meta-analyses and six new primary studies were added to the updated systematic review. Recommendations: Antibacterial and antifungal prophylaxis is recommended for patients who are at high risk of infection, including patients who are expected to have profound, protracted neutropenia, which is defined as < 100 neutrophils/µL for > 7 days or other risk factors. Herpes simplex virus–seropositive patients undergoing allogeneic hematopoietic stem-cell transplantation or leukemia induction therapy should receive nucleoside analog-based antiviral prophylaxis, such as acyclovir. Pneumocystis jirovecii prophylaxis is recommended for patients receiving chemotherapy regimens that are associated with a > 3.5% risk for pneumonia as a result of this organism (eg, those with ≥ 20 mg prednisone equivalents daily for ≥ 1 month or on the basis of purine analog usage). Treatment with a nucleoside reverse transcription inhibitor (eg, entecavir or tenofovir) is recommended for patients at high risk of hepatitis B virus reactivation. Recommendations for vaccination and avoidance of prolonged contact with environments that have high concentrations of airborne fungal spores are also provided within the updated guideline. Additional information is available at www.asco.org/supportive-care-guidelines .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Self-citationBODEY, G. P., BUCKLEY, M., SATHE, Y. S., & FREIREICH, E. J. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-2-328 · Cited by 2,469
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Self-citation2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Self-citationMortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
Kuderer, N. M., Dale, D. C., Crawford, J., Cosler, L. E., & Lyman, G. H. (2006) · Cancer · doi:10.1002/cncr.21847 · Cited by 1,176
Klastersky, J., Paesmans, M., Rubenstein, E. B., Boyer, M., Elting, L., Feld, R., Gallagher, J., Herrstedt, J., Rapoport, B., Rolston, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3038 · Cited by 1,171
Self-citationFinancial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer
Ramsey, S. D., Bansal, A., Fedorenko, C. R., Blough, D. K., Overstreet, K. A., Shankaran, V., & Newcomb, P. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.6620 · Cited by 912
Smith, T. J., Bohlke, K., Lyman, G. H., Carson, K. R., Crawford, J., Cross, S. J., Goldberg, J. M., Khatcheressian, J. L., Leighl, N. B., Perkins, C. L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.3488 · Cited by 904
Ramsey, S., Blough, D., Kirchhoff, A., Kreizenbeck, K., Fedorenko, C., Snell, K., Newcomb, P., Hollingworth, W., & Overstreet, K. (2013) · Health Affairs · doi:10.1377/hlthaff.2012.1263 · Cited by 699
Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
Sonis, S. T., Oster, G., Fuchs, H., Bellm, L., Bradford, W. Z., Edelsberg, J., Hayden, V., Eilers, J., Epstein, J. B., LeVeque, F. G., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2201 · Cited by 678
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
Bucaneve, G., Micozzi, A., Menichetti, F., Martino, P., Dionisi, M. S., Martinelli, G., Allione, B., D'Antonio, D., Buelli, M., Nosari, A. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044097 · Cited by 648
Romaguera, J. E., Fayad, L., Rodriguez, M. A., Broglio, K. R., Hagemeister, F. B., Pro, B., McLaughlin, P., Younes, A., Samaniego, F., Goy, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.1825 · Cited by 557
Talcott, J. A., Siegel, R. D., Finberg, R., & Goldman, L. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.2.316 · Cited by 545
Aapro, M. S., Cameron, D. A., Pettengell, R., Bohlius, J., Crawford, J., Ellis, M., Kearney, N., Lyman, G. H., Tjan-Heijnen, V. C., Walewski, J., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.05.002 · Cited by 539
Flowers, C. R., Seidenfeld, J., Bow, E. J., Karten, C., Gleason, C., Hawley, D. K., Kuderer, N. M., Langston, A. A., Marr, K. A., Rolston, K. V. I., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.8661 · Cited by 448
Self-citationTaplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6211 · Cited by 426
Self-citationTomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. J. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2009.254 · Cited by 387
Schiffer, C. A., Mangu, P. B., Wade, J. C., Camp-Sorrell, D., Cope, D. G., El-Rayes, B. F., Gorman, M., Ligibel, J., Mansfield, P., & Levine, M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5733 · Cited by 368
Talcott, J. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.12.2561 · Cited by 363
Lyman, G. H., Abella, E., & Pettengell, R. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.12.006 · Cited by 348
Fever and infection in leukemic patients.A study of 494 consecutive patients
Bodey, G. P., Rodriguez, V., Chang, H.-Y., & Narboni, G. (1978) · Cancer · doi:10.1002/1097-0142(197804)41:4<1610::aid-cncr2820410452>3.0.co;2-b · Cited by 325
Lyman, G. H., Dale, D. C., Friedberg, J., Crawford, J., & Fisher, R. I. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.213 · Cited by 315
Robenshtok, E., Gafter-Gvili, A., Goldberg, E., Weinberger, M., Yeshurun, M., Leibovici, L., & Paul, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3851 · Cited by 298
Brożek, J. L., Akl, E. A., Compalati, E., Kreis, J., Terracciano, L., Fiocchi, A., Ueffing, E., Andrews, J., Alonso-Coello, P., Meerpohl, J. J., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2010.02530.x · Cited by 297
Del Castillo, M., Romero, F. A., Argüello, E., Kyi, C., Postow, M. A., & Redelman-Sidi, G. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw539 · Cited by 294
Survival in neutropenic patients with severe sepsis or septic shock*
Legrand, M., Max, A., Peigne, V., Mariotte, E., Canet, E., Debrumetz, A., Lemiale, V., Seguin, A., Darmon, M., Schlemmer, B., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822b50c2 · Cited by 281
Huang, H., Li, X., Zhu, J., Ye, S., Zhang, H., Wang, W., Wu, X., Peng, J., Xu, B., Lin, Y., et al. (2014) · JAMA · doi:10.1001/jama.2014.15704 · Cited by 232
(2008) · Cited by 225
Trecarichi, E. M., Tumbarello, M., Spanu, T., Caira, M., Fianchi, L., Chiusolo, P., Fadda, G., Leone, G., Cauda, R., & Pagano, L. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.02.002 · Cited by 194
Shiffman, R. N., Michel, G., Rosenfeld, R. M., & Davidson, C. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000172 · Cited by 184
IDSA Sepsis Task Force, Kalil, A. C., Gilbert, D. N., Winslow, D. L., Masur, H., & Klompas, M. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix997 · Cited by 177
Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.
Blay, J., Chauvin, F., Cesne, A. L., Anglaret, B., Bouhour, D., Lasset, C., Freyer, G., Philip, T. O., & Biron, P. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.636 · Cited by 169
Carmona-Bayonas, A., Jiménez-Fonseca, P., Virizuela Echaburu, J., Antonio, M., Font, C., Biosca, M., Ramchandani, A., Martínez, J., Hernando Cubero, J., Espinosa, J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.2347 · Cited by 160
Gardner, A., Mattiuzzi, G. N., Faderl, S. H., Borthakur, G. M., Garcia‐Manero, G., Pierce, S. A., Brandt, M., & Estey, E. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4681 · Cited by 152
Pettengell, R., Schwenkglenks, M. M., Leonard, R. C., Bosly, A., Paridaens, R., Constenla, M., Szucs, T. D., & Jackisch, C. (2008) · Supportive Care in Cancer · doi:10.1007/s00520-008-0430-4 · Cited by 136
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy
for the ELYPSE study group, Ray-Coquard, I., Borg, C., Bachelot, T., Sebban, C., Philip, I., Clapisson, G., Cesne, A. L., Biron, P., Chauvin, F., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600724 · Cited by 133
Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients
Bow, E. J. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834cf054 · Cited by 128
Self-citationMozessohn, L., Chan, K., Feld, J. J., & Hicks, L. K. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12402 · Cited by 126
Ebbing, L., Metlay, J. P., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2005) · Clinical Infectious Diseases · doi:10.1086/432940 · Cited by 118
Sun, Y., Meng, F., Han, M., Zhang, X., Yu, L., Huang, H., Wu, D., Ren, H., Wang, C., Shen, Z., et al. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.03.018 · Cited by 113
Intragumtornchai, T., Sutheesophon, J., Sutcharitchan, P., & Swasdikul, D. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009089435 · Cited by 104
Hosmer, W., Malin, J. L., & Wong, M. D. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0821-1 · Cited by 89
Schwenkglenks, M. M., Jackisch, C., Constenla, M., Kerger, J. N., Paridaens, R., Auerbach, L., Bosly, A., Pettengell, R., Szucs, T. D., & Leonard, R. C. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0034-9 · Cited by 71
Rational Selection of Patients for Antibacterial Prophylaxis After Chemotherapy
Cullen, M. H., Billingham, L. J., Gaunt, C. H., & Steven, N. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.7395 · Cited by 62
Blennow, O., Remberger, M., Klingspor, L., Omazic, B., Fransson, K., Ljungman, P. T., Mattsson, J., & Ringdén, O. T. H. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.38 · Cited by 60
Kim, D. K., Riley, L. E., & Hunter, P. H. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6705e3 · Cited by 59
The Rise of Fluoroquinolone-Resistant Escherichia coli in the Community: Scarier Than We Thought
Spellberg, B. J., & Doi, Y. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv279 · Cited by 58
Sonbol, M. B., Firwana, B., Diab, M., Zarzour, A., & Witzig, T. E. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1082109 · Cited by 54
Bow, E. J., & Meddings, J. B. (2006) · Leukemia · doi:10.1038/sj.leu.2404440 · Cited by 54
Self-citationKlingspor, L., Saeedi, B., Ljungman, P. T., & Szakos, A. (2015) · Mycoses · doi:10.1111/myc.12344 · Cited by 53
Mucositis: from febrile neutropenia to febrile mucositis
Blijlevens, N. M. A., Logan, R. M., & Netea, M. G. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp081 · Cited by 43
Oğuz, A., Karadeniz, C., Ckitak, E. C., & Cil, V. (2006) · Pediatric Hematology and Oncology · doi:10.1080/08880010500457673 · Cited by 29
Acute myeloid leukemia in manitoba
Bow, E. J., Kilpartick, M. G., Scott, B. A., & Cheang, M. (1994) · Cancer · doi:10.1002/1097-0142(19940701)74:1<52::aid-cncr2820740110>3.0.co;2-g · Cited by 24
Self-citationA practical critique of antifungal treatment guidelines for haemato-oncologists
Agrawal, S. G., Jones, B., Barnes, R. A., et al. (2012) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.645521 · Cited by 14
Cited by
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Rejeski, K., Perez, A., Sesques, P., Hoster, E., Berger, C., Jentzsch, L., Mougiakakos, D., Frölich, L., Ackermann, J., Bücklein, V., et al. (2021) · Blood · doi:10.1182/blood.2020010543 · Cited by 475
COVID-19 in persons with haematological cancers
He, W., Chen, L., Chen, L., Yuan, G., Fang, Y., Chen, W., Wu, D., Liang, B., Lu, X., Ma, Y., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0836-7 · Cited by 462
Advances in acute myeloid leukemia
Newell, L. F., & Cook, R. J. (2021) · BMJ · doi:10.1136/bmj.n2026 · Cited by 440
Rejeski, K., Subklewe, M., Aljurf, M., Bachy, E., Balduzzi, A., Barba, P., Bruno, B., Benjamin, R., Carrabba, M. G., Chabannon, C., et al. (2023) · Blood · doi:10.1182/blood.2023020578 · Cited by 358
Metadata
- Authors
- Taplitz, R. A., Kennedy, E. B., Bow, E. J., Crews, J., Gleason, C., Hawley, D. K., Langston, A. A., Nastoupil, L. J., Rajotte, M., Rolston, K. V., Strasfeld, L., & Flowers, C. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2018-10-20
- Volume
- 36
- Issue
- 30
- Pages
- 3043-3054
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2890837116
- Cited by
- 601
- References
- 58
- FWCI
- 15.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.